Allogene Therapeutics
Price & Volume
Stats
See more52W Range | $0.86-$4.46 |
Market Cap | $555.8M |
Shares Short | 32M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$150.1M |
Diluted EPS | -$0.65 |
News
See moreYahoo Finance • 8 hours ago
Allogene Prices $175 Mln Offering At $2 Per Share; Stock Down
Yahoo Finance • 11 hours ago
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
Yahoo Finance • yesterday
Allogene Announces $175 Mln Public Offering
Yahoo Finance • 3 days ago
Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?
About
CEO | Dr. David D. Chang M.D., Ph.D. |
CFO | Mr. Geoffrey M. Parker |
Address | 210 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 150 |
